Variant report
Variant | nsv513244 |
---|---|
Chromosome Location | chr5:79900666-79904808 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:37)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:37 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr5:79903729-79903973 | HepG2 | liver: | n/a | n/a |
2 | ATF2 | chr5:79903635-79904100 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr5:79903692-79904084 | GM12878 | blood: | n/a | chr5:79903905-79903916 |
4 | BATF | chr5:79903672-79904079 | GM12878 | blood: | n/a | chr5:79903905-79903916 |
5 | CEBPB | chr5:79903738-79903757 | HepG2 | liver: | n/a | n/a |
6 | ELF1 | chr5:79903612-79904011 | HepG2 | liver: | n/a | n/a |
7 | ELF1 | chr5:79903751-79904073 | HepG2 | liver: | n/a | n/a |
8 | ELF1 | chr5:79903701-79904024 | GM12878 | blood: | n/a | n/a |
9 | FOXA1 | chr5:79903562-79904097 | HepG2 | liver: | n/a | n/a |
10 | FOXA1 | chr5:79903691-79904082 | HepG2 | liver: | n/a | n/a |
11 | FOXA1 | chr5:79903639-79903958 | HepG2 | liver: | n/a | n/a |
12 | FOXA1 | chr5:79903673-79904088 | HepG2 | liver: | n/a | n/a |
13 | FOXA2 | chr5:79903657-79904009 | HepG2 | liver: | n/a | n/a |
14 | HNF4A | chr5:79903603-79903973 | HepG2 | liver: | n/a | chr5:79903815-79903830 |
15 | HNF4A | chr5:79903708-79904061 | HepG2 | liver: | n/a | chr5:79903815-79903830 |
16 | IRF4 | chr5:79903660-79904147 | GM12878 | blood: | n/a | n/a |
17 | JUN | chr5:79901910-79902089 | K562 | blood: | n/a | n/a |
18 | JUND | chr5:79903732-79903744 | HepG2 | liver: | n/a | n/a |
19 | MAFF | chr5:79903627-79903764 | HepG2 | liver: | n/a | n/a |
20 | MAFK | chr5:79903482-79903901 | HepG2 | liver: | n/a | chr5:79903564-79903580 |
21 | MAFK | chr5:79903522-79903957 | HepG2 | liver: | n/a | chr5:79903564-79903580 |
22 | MAZ | chr5:79903828-79903875 | HepG2 | liver: | n/a | n/a |
23 | MEF2A | chr5:79901611-79902119 | GM12878 | blood: | n/a | n/a |
24 | MEF2A | chr5:79901748-79902095 | GM12878 | blood: | n/a | n/a |
25 | MEF2C | chr5:79901707-79902207 | GM12878 | blood: | n/a | chr5:79901924-79901939 |
26 | NFYB | chr5:79903633-79904003 | GM12878 | blood: | n/a | n/a |
27 | POLR2A | chr5:79904627-79904732 | Gliobla | brain: | n/a | n/a |
28 | POLR2A | chr5:79904791-79904860 | Gliobla | brain: | n/a | n/a |
29 | RAD21 | chr5:79903816-79903960 | HepG2 | liver: | n/a | n/a |
30 | RFX5 | chr5:79903523-79903654 | HepG2 | liver: | n/a | n/a |
31 | RUNX3 | chr5:79903719-79904095 | GM12878 | blood: | n/a | n/a |
32 | RUNX3 | chr5:79903707-79904114 | GM12878 | blood: | n/a | n/a |
33 | SMC3 | chr5:79903737-79903912 | HepG2 | liver: | n/a | n/a |
34 | SPI1 | chr5:79903729-79904020 | GM12891 | blood: | n/a | n/a |
35 | SPI1 | chr5:79903752-79903958 | GM12878 | blood: | n/a | n/a |
36 | USF2 | chr5:79903834-79903932 | HepG2 | liver: | n/a | n/a |
37 | ZNF143 | chr5:79903888-79904000 | GM12878 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DHFR-1 | chr5:79904442-79904764 | XLOC_004905 |
2 | lnc-DHFR-1 | chr5:79904496-79904764 | NONHSAT102410 |
No data |
No data |
Variant related genes | Relation type |
---|---|
DBIP2 | TF binding region |
ENSG00000113318 | chromatin interactions |
ENSG00000228716 | chromatin interactions |
ENSG00000251366 | chromatin interactions |
NAA25 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376829461 | chr5:79900696-79900697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs111331601 | chr5:79900697-79900698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189783514 | chr5:79900715-79900716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533990723 | chr5:79900736-79900737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557621975 | chr5:79900737-79900738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547589626 | chr5:79900757-79900758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570729824 | chr5:79900762-79900763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539315996 | chr5:79900778-79900779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567155066 | chr5:79900782-79900783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556167073 | chr5:79900794-79900795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113892166 | chr5:79900809-79900810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535202171 | chr5:79900843-79900844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553724933 | chr5:79900878-79900879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555029764 | chr5:79900946-79900947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571985148 | chr5:79900957-79900958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375201925 | chr5:79900958-79900959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147736472 | chr5:79900994-79900995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148720496 | chr5:79901016-79901017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553619496 | chr5:79901086-79901087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs836790 | chr5:79901151-79901152 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs186068671 | chr5:79901273-79901274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1019750 | chr5:79901279-79901280 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs142249384 | chr5:79901420-79901421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112229068 | chr5:79901435-79901436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372529562 | chr5:79901461-79901462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138617511 | chr5:79901479-79901480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527741492 | chr5:79901488-79901489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79617856 | chr5:79901499-79901500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144428110 | chr5:79901500-79901501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs66973156 | chr5:79901501-79901502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547624293 | chr5:79901510-79901511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs836789 | chr5:79901512-79901513 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs539769682 | chr5:79901545-79901546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35750284 | chr5:79901582-79901583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs386403 | chr5:79901688-79901689 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs569667974 | chr5:79901718-79901719 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs577742151 | chr5:79901843-79901844 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs573494030 | chr5:79901947-79901948 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs140494099 | chr5:79901948-79901949 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs425463 | chr5:79901952-79901953 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs190004653 | chr5:79901964-79901965 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs183243693 | chr5:79901982-79901983 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs113350269 | chr5:79902011-79902012 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs554390919 | chr5:79902040-79902041 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs117166115 | chr5:79902065-79902066 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs186451571 | chr5:79902115-79902116 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs115515313 | chr5:79902118-79902119 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs576780229 | chr5:79902140-79902141 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs190529485 | chr5:79902168-79902169 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs551323331 | chr5:79902201-79902202 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:79899400-79910200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr5:79901600-79902200 | Enhancers | GM12878-XiMat | blood |
3 | chr5:79902200-79902600 | Weak transcription | GM12878-XiMat | blood |
4 | chr5:79902400-79916600 | Weak transcription | Thymus | Thymus |
5 | chr5:79902600-79903600 | Enhancers | GM12878-XiMat | blood |
6 | chr5:79902600-79904000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr5:79902600-79904200 | Enhancers | Liver | Liver |
8 | chr5:79902800-79904800 | Enhancers | HepG2 | liver |
9 | chr5:79903000-79903600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
10 | chr5:79903400-79903800 | Enhancers | Primary B cells from cord blood | blood |
11 | chr5:79903600-79904000 | Flanking Active TSS | GM12878-XiMat | blood |
12 | chr5:79903600-79904000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
13 | chr5:79903600-79905000 | Enhancers | Primary monocytes fromperipheralblood | blood |
14 | chr5:79903600-79905000 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
15 | chr5:79904000-79904800 | ZNF genes & repeats | GM12878-XiMat | blood |
16 | chr5:79904000-79905000 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
17 | chr5:79904000-79905600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
18 | chr5:79904000-79914400 | Weak transcription | Dnd41 | blood |
19 | chr5:79904800-79925000 | Weak transcription | Primary B cells from cord blood | blood |